# Huajin Dadao Investment

Huajin Dadao Investment is a Corporate Investor based in Shanghai, China.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Shanghai, China
- **Region:** Asia
- **Address:** Shanghai, China
- **Founded:** 2019
- **Assets under management:** Undisclosed
- **Website:** huajinsc.cn

## Regulatory record

- **Reports private funds:** No

## About

Huajin Dadao Investment formed in 2019 as the direct venture investment arm of Huajin Securities, a brokerage firm ultimately controlled by the Zhuhai Huafa Group, a major state-owned enterprise based in Zhuhai. The firm invests balance-sheet capital into early-to-growth-stage Chinese companies, leveraging its parent's financial infrastructure and regional government ties. The firm targets venture and growth equity opportunities across three primary sectors: energy transition and renewables, healthcare services and biotech, and information technology. Deal flow is shaped by Huajin Securities' broader corporate and government relationships in Shanghai and the Greater Bay Area. The firm frequently co-invests alongside Huajin Capital, a listed affiliate under the same ultimate parent, and has partnered with entities such as Simcere Pharmaceutical in healthcare and biotech rounds. While the firm operates nationally, its activity concentrates in China's eastern and southern economic corridors. As a wholly-owned subsidiary, Huajin Dadao Investment operates without external limited partners, giving it flexible holding periods and the capacity to act on strategic alignment rather than pure financial return mandates. The firm's ultimate parent, Zhuhai Huafa Group, holds substantial assets spanning real estate, financial services, and industrial operations, though precise AUM or deployment figures for Huajin Dadao Investment are not publicly disclosed. Structurally, the firm functions as a corporate venture unit rather than an independent fund manager. Its investment committee and deal execution are closely integrated with Huajin Securities' broader capital-markets operations, enabling portfolio companies to access follow-on public-market financing through the parent brokerage's underwriting and advisory capabilities. This embedded financial-services architecture differentiates it from standalone venture firms in China's competitive early-stage market.

## Sectors

- Energy Transition & Renewables
- Healthcare Services
- Enterprise Software

## Questions

### What is the relationship between Huajin Dadao Investment and Huajin Capital?

Both entities sit under the Zhuhai Huafa Group umbrella and frequently co-invest. Huajin Capital is a publicly listed entity engaged in equity investment and asset management. The two firms have partnered on technology and healthcare deals, sharing deal flow and due diligence within the parent group's investment ecosystem.

### Does Huajin Dadao Investment invest from a fund or a balance sheet?

The firm invests directly from the balance sheet of Huajin Securities, not from a pooled third-party fund structure. This gives it permanent capital with no fixed investment period or mandated exit timelines. It does not publicly solicit outside investors or report fund-level performance metrics.

### Which sectors does Huajin Dadao Investment focus on?

Three sectors dominate: energy, healthcare, and information technology. Within healthcare, the firm has co-invested alongside Simcere Pharmaceutical in biotech rounds. Its energy exposure spans China's energy-transition landscape, while IT investments cover enterprise software and digital infrastructure aligned with state industrial priorities.

## Related profiles

- [Huainan Mining Group](https://altss.com/profile/huainan-mining-group)
- [Huajun Pharmaceutical Group](https://altss.com/profile/huajun-pharmaceutical-group)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/huajin-dadao-investment

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology